Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
HiFiBiO Therapeutics
Indiana University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Indiana University
Duke University
Duke University
European Organisation for Research and Treatment of Cancer - EORTC